Wright JJ - Search Results

1

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.

Tolaney SM, Tan S, Guo H, Barry W, Van Allen E, Wagle N, Brock J, Larrabee K, Paweletz C, Ivanova E, Janne P, Overmoyer B, Wright JJ, Shapiro GI, Winer EP, Krop IE. Tolaney SM, et al. Among authors: wright jj. Invest New Drugs. 2015 Oct;33(5):1108-14. doi: 10.1007/s10637-015-0269-8. Epub 2015 Jul 1. Invest New Drugs. 2015. PMID: 26123926 Free PMC article. Clinical Trial.

2

A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.

Shapiro GI, Supko JG, Patterson A, Lynch C, Lucca J, Zacarola PF, Muzikansky A, Wright JJ, Lynch TJ Jr, Rollins BJ. Shapiro GI, et al. Among authors: wright jj. Clin Cancer Res. 2001 Jun;7(6):1590-9. Clin Cancer Res. 2001. PMID: 11410495 Clinical Trial.

3

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.

Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD. Dahut WL, et al. Among authors: wright jj. J Clin Oncol. 2004 Jul 1;22(13):2532-9. doi: 10.1200/JCO.2004.05.074. J Clin Oncol. 2004. PMID: 15226321 Clinical Trial.

4

A phase II study of perifosine in androgen independent prostate cancer.

Posadas EM, Gulley J, Arlen PM, Trout A, Parnes HL, Wright J, Lee MJ, Chung EJ, Trepel JB, Sparreboom A, Chen C, Jones E, Steinberg SM, Daniels A, Figg WD, Dahut WL. Posadas EM, et al. Cancer Biol Ther. 2005 Oct;4(10):1133-7. doi: 10.4161/cbt.4.10.2064. Epub 2005 Oct 1. Cancer Biol Ther. 2005. PMID: 16138006 Free article. Clinical Trial.

5

A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia.

Gomez-Abuin G, Winquist E, Stadler WM, Pond G, Degendorfer P, Wright J, Moore MJ. Gomez-Abuin G, et al. Invest New Drugs. 2007 Apr;25(2):181-5. doi: 10.1007/s10637-006-9009-4. Epub 2006 Sep 16. Invest New Drugs. 2007. PMID: 16983508 Clinical Trial.

6

A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy.

Lieu C, Chow L, Pierson AS, Eckhardt SG, O'Bryant CL, Morrow M, Tran ZV, Wright JJ, Gore L. Lieu C, et al. Among authors: wright jj. Invest New Drugs. 2009 Feb;27(1):53-62. doi: 10.1007/s10637-008-9154-z. Epub 2008 Jul 11. Invest New Drugs. 2009. PMID: 18618082 Free PMC article. Clinical Trial.

7

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.

Aragon-Ching JB, Jain L, Gulley JL, Arlen PM, Wright JJ, Steinberg SM, Draper D, Venitz J, Jones E, Chen CC, Figg WD, Dahut WL. Aragon-Ching JB, et al. Among authors: wright jj. BJU Int. 2009 Jun;103(12):1636-40. doi: 10.1111/j.1464-410X.2008.08327.x. Epub 2009 Jan 9. BJU Int. 2009. PMID: 19154507 Free PMC article. Clinical Trial.

8

Phase I study of oral lenalidomide in patients with refractory metastatic cancer.

Dahut WL, Aragon-Ching JB, Woo S, Tohnya TM, Gulley JL, Arlen PM, Wright JJ, Ventiz J, Figg WD. Dahut WL, et al. Among authors: wright jj. J Clin Pharmacol. 2009 Jun;49(6):650-60. doi: 10.1177/0091270009335001. J Clin Pharmacol. 2009. PMID: 19451403 Free PMC article. Clinical Trial.

9

A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.

Sridhar SS, Winquist E, Eisen A, Hotte SJ, McWhirter E, Tannock IF, Mukherjee SD, Wang L, Blattler C, Wright JJ, Moore MJ. Sridhar SS, et al. Among authors: wright jj. Invest New Drugs. 2011 Oct;29(5):1045-9. doi: 10.1007/s10637-010-9408-4. Epub 2010 Feb 27. Invest New Drugs. 2011. PMID: 20191303 Clinical Trial.

10

A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.

Shah MA, Power DG, Kindler HL, Holen KD, Kemeny MM, Ilson DH, Tang L, Capanu M, Wright JJ, Kelsen DP. Shah MA, et al. Among authors: wright jj. Invest New Drugs. 2011 Dec;29(6):1475-81. doi: 10.1007/s10637-010-9474-7. Epub 2010 Jun 25. Invest New Drugs. 2011. PMID: 20574790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters